All Stories

  1. Current practices in HPV-related anogenital neoplasia care in Europe – a survey analysis
  2. The challenging approach to the management of male partners of HPV-positive women
  3. Imiquimod for Anal High Grade Intraepithelial Neoplasia: A Systematic Review
  4. What Are Consumers Looking for With Boric Acid?
  5. Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European ...
  6. Will artificial intelligence be the answer for the gap in vulvovaginal diseases?
  7. When did the confusion between vulvodynia and vaginismus start?
  8. Polymicrobial Consortia in the Pathogenesis of Biofilm Vaginosis Visualized by FISH. Historic Review Outlining the Basic Principles of the Polymicrobial Infection Theory
  9. Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality
  10. Evaluation of Host Gene Methylation as a Triage Test for HPV–Positive Women—A Cohort Study
  11. Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
  12. The genital tract microbiome: bridging the gap between hype and clinical reality
  13. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
  14. Is Vulvodynia Associated With an Altered Vaginal Microbiota?: A Systematic Review
  15. The International Society for the Study of Vulvovaginal Disease (ISSVD) Vulvar Awareness Day Campaign: Knowledge of Vulvovaginal Diseases Among Italian Obstetrics and Gynecology Residents
  16. Genital and extragenital oncological risk in women with vulvar lichen sclerosus: A multi-center Italian study
  17. Chlamydial and Gonococcal Genital Infections: A Narrative Review
  18. Low genitourinary tract risks in women living with the human immunodeficiency virus
  19. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus St...
  20. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus st...
  21. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer
  22. Scoping review of cytolytic vaginosis literature
  23. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis
  24. Chronic Hypertrophic Herpes Simplex Infection: A 13-Year Delay
  25. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
  26. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
  27. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review
  28. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream
  29. Vaginal Leptothrix: An Innocent Bystander?
  30. Changes in the Vaginal Microbiota of Women With Secondary Localized Provoked Vulvodynia
  31. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus sta...
  32. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Sta...
  33. Early Diagnostics of Vulvar Intraepithelial Neoplasia
  34. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments: A Cross-sectional Study: Erratum
  35. Risk Factors for Positive Margins in High-Grade Cervical Intraepithelial Neoplasia After Transformation Zone Excision
  36. Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review
  37. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments
  38. COVID-19 related acute genital ulcer: a case report
  39. The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
  40. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
  41. The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
  42. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
  43. The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
  44. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
  45. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
  46. Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
  47. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic
  48. Surgical treatment for provoked vulvodynia – Where do we stand? A narrative review
  49. G-spot: Fact or Fiction?: A Systematic Review
  50. Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
  51. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross‐sectional study
  52. Cytology Is Not Reliable to Evaluate Cervical Disease Regression
  53. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
  54. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
  55. For Anal Cancer, Not All Women Are Equal
  56. Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study
  57. Clarification about vulvar cancer precursor lesions
  58. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation
  59. Knowledge of Vulvar Anatomy and Self-examination in a Sample of Italian Women
  60. Letter to the editor: “Do variations in labial anatomy have an effect on recurrent urinary tract infection?”
  61. Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia
  62. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
  63. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
  64. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study
  65. Better studies needed on LASER use in urinary incontinence
  66. Prognostic factors in patients with vulvar cancer: the VULCAN study
  67. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  68. Better triage tests needed for HPV‐positive women
  69. Adult Vulvar Lichen Sclerosus: Can Experts Agree on the Assessment of Disease Severity?
  70. Corrigendum
  71. The International Classification of Diseases, 11th Revision: A Step-Back for Women With Vulvodynia?
  72. Diagnosis of vaginitis: time to improve and move on
  73. Response letter to comments related to “The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document”
  74. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women
  75. Vulvodynia: a neglected chronic pain diagnosis
  76. Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories
  77. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)
  78. Impact of the Sampling Site in the Result of Wet Mount Microscopy
  79. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document
  80. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  81. The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion
  82. Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?
  83. Vulvodynia: A disease commonly hidden in plain sight
  84. International Society for the Study of Vulvovaginal Disease Recommendations Regarding Female Cosmetic Genital Surgery
  85. To the Editor:
  86. Bioengineering Organs for Blood Detoxification
  87. The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
  88. Diagnosis and management of vulvodynia in postmenopausal women
  89. Aerobic vaginitis: no longer a stranger
  90. Clinical Validation of a Test for the Diagnosis of Vaginitis: Correction
  91. Clinical Validation of a Test for the Diagnosis of Vaginitis
  92. Lichen sclerosus in women: a review
  93. Survey on Aesthetic Vulvovaginal Procedures: What do Portuguese Doctors and Medical Students Think?
  94. Women without vulvodynia can have a positive ‘Q-tip test’: a cross sectional study
  95. P-04-003 Prevalence of Sexually Transmitted Diseases Among Women in Principe Island
  96. Deconstructing the genitourinary syndrome of menopause
  97. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island
  98. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
  99. Is the DSM-V Leading to the Nondiagnosis of Vulvodynia?
  100. Lipschütz ulcers: should we rethink this? An analysis of 33 cases
  101. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
  102. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
  103. The “Genitourinary Syndrome of Menopause”
  104. Emphysematous Vaginitis
  105. What Differentiates Symptomatic from Asymptomatic Women with Lichen Sclerosus?
  106. Prevalence of vulvodynia and risk factors for the condition in Portugal
  107. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
  108. Mycoplasma pneumoniae
  109. Lichen Sclerosus in Breast Cancer Survivor
  110. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
  111. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125
  112. Case report: intra-partum utero-ovarian vessels rupture
  113. Use of extensible internal device in the femur of young dogs
  114. L-band land mobile satellite (LMS) amplitude and multipath phase modeling in urban areas
  115. Mobile and Base Station Diversity Simulation Experiments in a Mobile Communications Course